{"timestamp": 1771602966.2514985, "value": {"ticker": "ACRV", "company_name": "Acrivon Therapeutics, Inc.", "short_name": "Acrivon Therapeutics, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 49068220, "float_shares": 16867793, "shares_outstanding": 31555126, "short_ratio": 0.6, "short_percent_of_float": 0.16950001, "shares_short": 2024627, "shares_short_prior": 5325324, "insider_percent_held": 0.20567, "institution_percent_held": 0.59002995, "total_cash": 129254000, "total_debt": 2989000, "total_revenue": 0, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": 0.0, "debt_to_equity": 2.324, "current_ratio": 8.754, "book_value": 4.076, "price_to_book": 0.38150144, "operating_cashflow": -65788000, "free_cashflow": -40886000, "price": 1.555, "52w_high": 6.08, "52w_low": 1.05, "avg_volume": 1569143, "avg_volume_10d": 730790, "full_time_employees": 75, "audit_risk": 0, "overall_risk": 0}}